Torrent Pharmaceuticals
TORNTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Samir Mehta Listing date: Oct. 24, 1994 · Employees: 13505 · Ahmedabad · http://www.torrentpharma.com

Stock Price vs Company Growth
1d
0.3%
1w
0.1%
1m
7.0%
3m
7.3%
6m
15.6%
1y
48.4%
5y
31.2%
10y
21.6%
all
27.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 3,105 0.3%
3,061
3,590
Company Overview

Sales
11,225 Cr
Growth: 10.5%
Profit after Tax
1,714 Cr
Growth: 4.1%
Large Cap
1,05,072 Cr
P/E: 58.3x
Industry P/E: 35.6x
Fundamentals

Sales (Cr) ₹ 11,225
Growth 10.5%
EBITDA 32.0%
P/S 9.4x
Dividend 1.3%
P/E 58.3x
Book Value ₹ 229
PEG Ratio 5.6x
ROE 23.4%
P/B 13.5x
Shareholding Pattern

Institutions
Mirae Asset Focused Fund
2.16 %
Qualified Institutional Buyer
1.63 %
Uti-Unit Linked Insurance Plan
1.28 %
Promoters
Torrent Investments Private Limited
71.25 %
Others
Ifpf
0.1 %
Increase    Decrease    No change
Company Profile Detailed

Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).
Investors (87)
Followers (11)